Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S‐ketamine
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Journal of Pain
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2135645785
